covid-19 pandemic information vaccine

Access to Covid-19 vaccines: MSF’s concerns about Gavi’s COVAX AMC

Reading now: 173
www.pharmaceutical-technology.com

Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.In April, the WHO created the ACT-Accelerator with the overarching goal to deliver equitable access to diagnostics, treatments and vaccines for Covid-19.

As part of the vaccines pillar of the accelerator, Gavi has developed a COVAX Facility and advanced market commitment (AMC) initiative that aims to de-risk Covid-19 vaccine development, as well as ensure fair allocation of vaccines based on need rather than economic might.

However, global health charity Médicins San Frontières (MSF) has concerns about the ability of Gavi’s COVAX Facility and AMC mechanism to ensure equitable access to Covid-19 vaccines.

Read more on pharmaceutical-technology.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA